Liposomal doxorubicin improves response to immune checkpoint blockade by enhancing innate immunity in a murine model of oral cavity squamous cell carcinoma

被引：0
|
作者：
Anderson, Jennifer L.
Da Costa, Fabio H. Brasil
Nipper, Allison
Devkota, Laxman
Bhavane, Rohan
Veeramachaneni, Ratna
Cortes, Sofia
Dharmaraj, Neeraja
Latka, Sarah
Badachhape, Andrew
Menon, Renuka T. R.
Bhandari, Prajwal
Ghaghada, Ketankumar
Young, Simon
Annapragada, Ananth
Sikora, Andrew
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2025年 / 13卷 / 02期
关键词：
D O I：
10.1158/2326-6074.IO2025-A119
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A119
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma
    Zolkind, Paul
    Przybylski, Dariusz
    Marjanovic, Nemanja
    Lan Nguyen
    Lin, Tianxiang
    Johanns, Tanner
    Alexandrov, Anton
    Zhou, Liye
    Allen, Clint T.
    Miceli, Alexander P.
    Schreiber, Robert D.
    Artyomov, Maxim
    Dunn, Gavin P.
    Uppaluri, Ravindra
    ONCOTARGET, 2018, 9 (03) : 4109 - 4119
  • [2] Immune Checkpoint Blockade in cutaneous Squamous Cell Carcinoma
    Hauschild, A.
    HNO, 2019, 67 (04) : 239 - 239
  • [3] Innate immune responses against oral squamous carcinoma in an orthotopic murine model
    Rasul, Muhammad I.
    Tachinami, Hidetake
    Sasaki, Soichiro
    Susukida, Takeshi
    Noguchi, Makoto
    Hayakawa, Yoshihiro
    CANCER SCIENCE, 2023, 114 : 459 - 459
  • [4] Crenolanib improves PD-1 response and overall survival in immune checkpoint inhibitor resistant murine models of oral squamous cell carcinoma
    Shen, Xiangfeng
    Gonzalez, Katherine
    Castillo, Rico
    Rickard, Ashlyn
    Mowery, Yvonne
    Watts, Tammara
    CLINICAL CANCER RESEARCH, 2023, 29 (18)
  • [5] Immune checkpoint blockade therapy for esophageal squamous cell carcinoma
    Harada, Kazuto
    Kaya, Dilsa Mizrak
    Baba, Hideo
    Ajani, Jaffer A.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 699 - 702
  • [6] Immune Checkpoint Inhibitors in Oral Cavity Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review
    Kujan, Omar
    van Schaijik, Bede
    Farah, Camile S.
    CANCERS, 2020, 12 (07) : 1 - 25
  • [7] The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation
    Kenison, Jessica E.
    Wang, Zhongyan
    Yang, Kangkang
    Snyder, Megan
    Quintana, Francisco J.
    Sherr, David H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (19)
  • [8] Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
    Valero, Cristina
    Golkaram, Mahdi
    Vos, Joris L.
    Xu, Bin
    Fitzgerald, Conall
    Lee, Mark
    Kaplan, Shannon
    Han, Catherine Y.
    Pei, Xin
    Sarkar, Reith
    Boe, Lillian A.
    Pandey, Abhinav
    Koh, Elizabeth S.
    Zuur, Charlotte L.
    Solit, David B.
    Pawlowski, Traci
    Liu, Li
    Ho, Alan L.
    Chowell, Diego
    Riaz, Nadeem
    Chan, Timothy A.
    Morris, Luc G. T.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (19):
  • [9] Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade
    Wang, Liangliang
    Gao, Yan
    Zhang, Gao
    Li, Dan
    Wang, Zhenda
    Zhang, Jie
    Hermida, Leandro C.
    He, Lei
    Wang, Zhisong
    Si, Jingwen
    Geng, Shuang
    Ai, Rizi
    Ning, Fei
    Cheng, Chaoran
    Deng, Haiteng
    Dimitrov, Dimiter S.
    Sun, Yan
    Huang, Yanyi
    Wang, Dong
    Hu, Xiaoyu
    Wei, Zhi
    Wang, Wei
    Liao, Xuebin
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (560)
  • [10] Immune checkpoint blockade in esophageal squamous cell carcinoma: is it ready for prime time?
    Pectasides, Eirini
    JOURNAL OF THORACIC DISEASE, 2018, 10 (03) : 1276 - 1279
12345